Targeting GGTase-I Activates RHOA, Increases Macrophage Reverse Cholesterol Transport, and Reduces Atherosclerosis in Mice
Author(s) -
Omar M. Khan,
Murali K. Akula,
Kristina Skålén,
Christin Karlsson,
Marcus Ståhlman,
Stephen G. Young,
Jan Borén,
Martin O. Bergö
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.000588
Subject(s) - rhoa , scavenger receptor , cd36 , geranylgeranylation , inflammation , macrophage , proinflammatory cytokine , endocrinology , cholesterol , medicine , foam cell , chemistry , receptor , microbiology and biotechnology , biology , lipoprotein , signal transduction , prenylation , biochemistry , in vitro , enzyme
Statins have antiinflammatory and antiatherogenic effects that have been attributed to inhibition of RHO protein geranylgeranylation in inflammatory cells. The activity of protein geranylgeranyltransferase type I (GGTase-I) is widely believed to promote membrane association and activation of RHO family proteins. However, we recently showed that knockout of GGTase-I in macrophages activates RHO proteins and proinflammatory signaling pathways, leading to increased cytokine production and rheumatoid arthritis. In this study, we asked whether the increased inflammatory signaling of GGTase-I-deficient macrophages would influence the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom